TrialJournal of psychopharmacology (Oxford, England)2017

A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.

Cynthia Richards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.